Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HD vs MRNA✓SelectedUSD · MRNAHD vs MRNA performance historyLatest closeAs of+0.12%11/13
Stock and ETF performance explorer

HD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+30.7%
MRNA return
+221.0%
Excess return
-190.2%
Maximum drawdown
-31.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.1%-3.4%+3.6%+0.2%
7D+1.5%-12.1%+13.6%+1.9%
30D+18.0%-1.3%+19.3%+17.9%
3M+2.8%+250.9%-248.1%-2.8%
6M+17.0%+343.0%-326.0%+8.3%
YTD+3.5%+657.4%-653.9%-8.0%
1Y-2.6%+794.9%-797.5%-14.6%
3Y+30.7%+218.1%-187.4%+7.7%
All+30.7%+221.0%-190.2%+7.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling